Exman, Pedro
Mallery, Robert M.
Lin, Nancy U.
Parsons, Heather A. http://orcid.org/0000-0001-8178-6612
Article History
Received: 23 July 2019
Accepted: 30 October 2019
First Online: 29 November 2019
Competing interests
: N.L. reports institutional research funding from Genentech, Seattle Genetics, and Merck, and a consulting role for Seattle Genetics, Puma, and Daichii. H.P. reports an advisory role in Foundation Medicine, Inc., and institutional research funding from Puma Biotechnology. All other authors report no disclosures.